Literature DB >> 29391149

Surgical Treatment of Multifocal Pulmonary Mucormycosis.

Sara E A Mills1, Anjana V Yeldandi2, David D Odell3.   

Abstract

Mucormycosis is a devastating opportunistic fungal infection to which the immunosuppressed are particularly vulnerable. We report the case of a 60-year-old man who was found to have multifocal pulmonary mucormycosis 10 weeks after concomitant heart and kidney transplantation. Despite appropriate antifungal therapy, the infection progressed rapidly and soon involved critical pulmonary vasculature. He successfully underwent staged operative resection of his pulmonary mucormycosis without recurrence of infection. Although surgical debridement of pulmonary mucormycosis is typically reserved for localized disease, this case demonstrates that surgical intervention should be considered as an adjunct to antifungal therapy in multifocal disease.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29391149      PMCID: PMC6085879          DOI: 10.1016/j.athoracsur.2017.12.033

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

Review 1.  Pulmonary mucormycosis.

Authors:  Georgios Hamilos; George Samonis; Dimitrios P Kontoyiannis
Journal:  Semin Respir Crit Care Med       Date:  2011-12-13       Impact factor: 3.119

Review 2.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

Review 3.  Mucormycosis: New Developments into a Persistently Devastating Infection.

Authors:  François Danion; Claire Aguilar; Emilie Catherinot; Alexandre Alanio; Susan DeWolf; Olivier Lortholary; Fanny Lanternier
Journal:  Semin Respir Crit Care Med       Date:  2015-09-23       Impact factor: 3.119

Review 4.  Pulmonary mucormycosis: the last 30 years.

Authors:  F Y Lee; S B Mossad; K A Adal
Journal:  Arch Intern Med       Date:  1999-06-28

5.  Pulmonary Mucormycosis Treated With Lobectomy.

Authors:  Oluwatobi Afolayan; Hannah Copeland; Salman Zaheer; Jason M Wallen
Journal:  Ann Thorac Surg       Date:  2017-06       Impact factor: 4.330

6.  Pulmonary mucormycosis: clinical features and outcomes.

Authors:  Erica Lin; Teng Moua; Andrew H Limper
Journal:  Infection       Date:  2017-02-20       Impact factor: 3.553

Review 7.  Pulmonary mucormycosis: results of medical and surgical therapy.

Authors:  M Tedder; J A Spratt; M P Anstadt; S S Hegde; S D Tedder; J E Lowe
Journal:  Ann Thorac Surg       Date:  1994-04       Impact factor: 4.330

8.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

Authors:  O A Cornely; S Arikan-Akdagli; E Dannaoui; A H Groll; K Lagrou; A Chakrabarti; F Lanternier; L Pagano; A Skiada; M Akova; M C Arendrup; T Boekhout; A Chowdhary; M Cuenca-Estrella; T Freiberger; J Guinea; J Guarro; S de Hoog; W Hope; E Johnson; S Kathuria; M Lackner; C Lass-Flörl; O Lortholary; J F Meis; J Meletiadis; P Muñoz; M Richardson; E Roilides; A M Tortorano; A J Ullmann; A van Diepeningen; P Verweij; G Petrikkos
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067

  8 in total
  5 in total

1.  Management of Pulmonary Mucormycosis After Orthotopic Heart Transplant: A Case Series.

Authors:  Michael C Hill; Mark N Belkin; Phillip McMullen; Jessica J Pillarella; Greg P Macaluso; Adam N Treitman; Pat S Pappas; Antone J Tatooles; William G Cotts; Ambar A Andrade; Gene Kim; Nikhil Narang
Journal:  Transplant Proc       Date:  2021-11-10       Impact factor: 1.014

2.  Characteristics of pulmonary mucormycosis and the experiences of surgical resection.

Authors:  Weipeng Shao; Jun Zhang; Shanwu Ma; Hongxiang Feng; Zhenrong Zhang; Chaoyang Liang; Deruo Liu
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

Review 3.  Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic.

Authors:  Ayushi Sharma; Anjana Goel
Journal:  Folia Microbiol (Praha)       Date:  2022-02-26       Impact factor: 2.629

Review 4.  Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.

Authors:  Valliappan Muthu; Ritesh Agarwal; Atul Patel; Soundappan Kathirvel; Ooriapadickal Cherian Abraham; Ashutosh Nath Aggarwal; Amanjit Bal; Ashu Seith Bhalla; Prashant N Chhajed; Dhruva Chaudhry; Mandeep Garg; Randeep Guleria; Ram Gopal Krishnan; Arvind Kumar; Uma Maheshwari; Ravindra Mehta; Anant Mohan; Alok Nath; Dharmesh Patel; Shivaprakash Mandya Rudramurthy; Puneet Saxena; Nandini Sethuraman; Tanu Singhal; Rajeev Soman; Balamugesh Thangakunam; George M Varghese; Arunaloke Chakrabarti
Journal:  Lancet Infect Dis       Date:  2022-04-04       Impact factor: 71.421

5.  Successful treatment of pulmonary mucormycosis (Lichtheimia spp.) in a post-partum patient with COVID-19 ARDS requiring extra-corporeal membrane oxygenation using salvage therapy.

Authors:  Justin Hanks; Shinya Unai; Alejandro Bribriesco; Steven Insler; Eileen Yu; Jona Banzon; Eduardo Mireles-Cabodevila; Ahmad Adi; Haytham Elgharably; James Yun; Sudhir Krishnan
Journal:  Perfusion       Date:  2022-08-17       Impact factor: 1.581

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.